Skip to content

Sub-clinical Hypothyroidism management in Ayurveda

Effect of Shigru (Moringa oleifera Linn.) Patra choorna Tablet in the management of Subclinical Hypothyroidism-an open labelled clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048317
Enrollment
30
Registered
2022-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E038- Other specified hypothyroidism

Interventions

None listed

Sponsors

Dr Shubham Koundalkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient not on any Anti-thyroid medication. 2.Where TSH value is above normal value (0.35 to 5.0 mIU/L) but below 10mIU/L. 3.Individuals of either sex between the age group of 20 to 60 years fulfilling diagnostic criteria of subclinical hypothyroidism. 4.Fulfilling diagnostic criteria of sub clinical Hypothyroidism.

Exclusion criteria

Exclusion criteria: 1.Patient on Anti-thyroid medication. 2.Serum TSH value more than 10mIU/L. 3.Subjects with congenital hypothyroidism & Subjects who have undergone thyroid surgery. 4.Patients with complications of hypothyroidism like cardio vascular disorders, infertility, Myxedema coma etc. 5.Patients with alcohol dependency or drug dependency. 6.Pregnant or lactating women. 7.Patients suffering from major systemic illness and long term drug treatment Rheumatoid arthritis etc

Design outcomes

Secondary

MeasureTime frame
Inch loss in Waist circumference,Mid-Thigh and Mid-arm circumferenceTimepoint: 0th,15th.30th,42nd day

Primary

MeasureTime frame
Weight loss and inch lossTimepoint: 0th,42nd

Countries

India

Contacts

Public ContactDr Arun Chougale

KAHERS SHRI.B M KANKANWADI AYURVEDIC MAHAVIDYALAYA,SHAHAPUR,BELGAUM

punarjeevam@gmail.com9964749993

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026